Research
Impact of Sleep Disorder Treatments on Fatigue
Fatigue is one of the symptoms people with MS commonly experience, and for some, it’s the symptom that affects them the most. While the experience of fatigue varies from person to person, the effects can be felt both mentally and physically, leading fatigue to impact on daily life.
Is it MS? Survey Results
The Multiple Sclerosis International Federation (MSIF) has published the results of its ‘Is it MS?’ survey. The survey was carried out in early 2012 with over 4000 people taking part, sharing their experience of being diagnosed with MS.
FDA Consider Alemtuzumab
For a number of years we have mentioned the possibility of a new drug called Alemtuzumab being a potential new treatment for people with MS. On 12 June 2012 the makers, Genzyme, announced that the company has made an official application to the Food and Drugs Administration (FDA) in the US and the European Medicines Agency (EMA).
Gilenya Now Prescribed
Fingolimod, under the trade name Gilenya, the first oral drug therapy for the treatment of MS, is now available under the direction of a neurologist. Gilenya is licensed as a second line therapy, making it suitable for people that have failed on conventional first line therapies or those individuals with highly active MS.